Gamifant

Product manufactured by Novimmune Sa

Application Nr Approved Date Route Status External Links
BLA761107 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Gamifant Is Indicated For The Treatment Of Adult And Pediatric (Newborn And Older) Patients With Primary Hemophagocytic Lymphohistiocytosis (Hlh) With Refractory, Recurrent Or Progressive Disease Or Intolerance With Conventional Hlh Therapy. Gamifant Is An Interferon Gamma (Ifnγ) Blocking Antibody Indicated For The Treatment Of Adult And Pediatric (Newborn And Older) Patients With Primary Hemophagocytic Lymphohistiocytosis (Hlh) With Refractory, Recurrent Or Progressive Disease Or Intolerance With Conventional Hlh Therapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Emapalumab

Comments